Literature DB >> 12122862

Drug hepatotoxicity.

Zachary D Goodman1.   

Abstract

Drug-induced liver disease is a relatively common, but often unrecognized, cause of liver injury, primarily because the diagnosis is often not entertained clinically. In addition, drugs are great imitators, capable of producing nearly any clinical scenario and histopathologic lesion. Thus, when dealing with a liver biopsy from a patient with an undiagnosed liver disease, the diagnosis of drug hepatotoxicity is made by first having a high index of suspicion, and then by careful correlation of histopathologic findings with both clinical and laboratory data and with a search for appropriate precedents in the medical literature.

Entities:  

Mesh:

Year:  2002        PMID: 12122862     DOI: 10.1016/s1089-3261(02)00011-9

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

1.  Toxic hepatic injury mimicking ascending cholangitis: is Pyrus amygdaliformis to blame?

Authors:  Despoina Televantou; Emmanouil Sinakos; Evangelos A Akriviadis; Prodromos Hytiroglou
Journal:  Virchows Arch       Date:  2008-09-12       Impact factor: 4.064

Review 2.  An Update on Drug-induced Liver Injury.

Authors:  Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

3.  The Role of the Hepatopathologist in the Assessment of Drug-induced Liver Injury.

Authors:  David E Kleiner
Journal:  Clin Liver Dis (Hoboken)       Date:  2017-03-01

Review 4.  Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.

Authors:  Raúl-J Andrade; Mercedes Robles; Alejandra Fernández-Castañer; Susana López-Ortega; M-Carmen López-Vega; M-Isabel Lucena
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 5.  [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

Review 6.  Drug-Induced Mitochondrial Toxicity.

Authors:  Iain P Hargreaves; Mesfer Al Shahrani; Luke Wainwright; Simon J R Heales
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

Review 7.  Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.

Authors:  Aida Ortega-Alonso; Camilla Stephens; M Isabel Lucena; Raúl J Andrade
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

8.  CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Authors:  Yue-Cheng Yu; Yi-Min Mao; Cheng-Wei Chen; Jin-Jun Chen; Jun Chen; Wen-Ming Cong; Yang Ding; Zhong-Ping Duan; Qing-Chun Fu; Xiao-Yan Guo; Peng Hu; Xi-Qi Hu; Ji-Dong Jia; Rong-Tao Lai; Dong-Liang Li; Ying-Xia Liu; Lun-Gen Lu; Shi-Wu Ma; Xiong Ma; Yue-Min Nan; Hong Ren; Tao Shen; Hao Wang; Ji-Yao Wang; Tai-Ling Wang; Xiao-Jin Wang; Lai Wei; Qing Xie; Wen Xie; Chang-Qing Yang; Dong-Liang Yang; Yan-Yan Yu; Min-de Zeng; Li Zhang; Xin-Yan Zhao; Hui Zhuang
Journal:  Hepatol Int       Date:  2017-04-12       Impact factor: 6.047

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.